BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines External R&D by Year
External R&D — Other Internal Clinical & Preclinical Projects ($M) ($M)
BeOne Medicines External R&D: $312M in FY2025, up 44.8% from a year earlier. That is the highest of the 9 years on record here.
Latest, FY2025
312
Period ended Dec 31, 2025
Change on a year earlier
+44.8%
215 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| Other R&D projects | 311,557 | 215,139”
Reported in Form 8-K EX-99.1 SSE STAR Market Annual Reports (688235.SS).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | External R&D — Other Internal Clinical & Preclinical Projects ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 312 | +44.8% | 8-K STAR Report (2026-04-14, 0001651308-26-000008) ↗ |
| FY2024 | Dec 31, 2024 | 215 | -14.5% | 8-K STAR Report (2026-04-14, 0001651308-26-000008) ↗ |
| FY2023 | Dec 31, 2023 | 252 | +149.9% | 8-K STAR Report (2025-04-28, 0001651308-25-000057) ↗ |
| FY2022 | Dec 31, 2022 | 101 | +26.6% | 8-K STAR Report (2024-04-26, 0001651308-24-000043) ↗ |
| FY2021 | Dec 31, 2021 | 79.6 | +8.2% | 8-K STAR Report (2023-04-25, 0001651308-23-000061) ↗ |
| FY2020 | Dec 31, 2020 | 73.5 | -13.3% | 8-K STAR Report (2022-04-28, 0001651308-22-000058) ↗ |
| FY2019 | Dec 31, 2019 | 84.8 | +36.8% | 8-K STAR Report (2021-11-16, 0001651308-21-000229) ↗ |
| FY2018 | Dec 31, 2018 | 62.0 | +454.1% | 8-K STAR Report (2021-11-16, 0001651308-21-000229) ↗ |
| FY2017 | Dec 31, 2017 | 11.2 | – | 8-K STAR Report (2021-01-29, 0001104659-21-009496) ↗ |
Cite this data
StockData. (2026). BeOne Medicines External R&D ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rd-mol-other
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.